GEROSCIENCE-DRIVEN THERAPIES TO TARGET HEALTHSPAN WITH AGING: CLINICAL IMPLICATIONS

Abstract

The geroscience hypothesis posits that by targeting aging we may simultaneously prevent or delay several age-related diseases and thereby increase healthspan, or lifespan spent free of significant disease and disability. Clinical trials of candidate agents are underway to examine several pharmacological interventions for this purpose.